Skip to main content
SpringerLink
Log in

Cutaneous Lymphomas

  • Chapter
Skin Cancer after Organ Transplantation

Part of the book series: Cancer Treatment and Research ((CTAR,volume 146))

Post-transplant lymphoproliferative disorders (PTLDs) are a clinically and morphologically heterogeneous group of lymphoid proliferations, affecting up to 5% of immunosuppressed patients following solid organ or bone marrow transplantation [1]. In transplant recipients, PTLDs are the second most common form of neoplasias after skin cancers [2], having a variable incidence that is 25- to 50 fold greater than that of the general population [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–91.

    Article  PubMed  Google Scholar 

  2. Lutzner MA. Skin cancer in immunosuppressed organ transplant recipients. J Am Acad Dermatol 1984; 11:891–3.

    Article  PubMed  CAS  Google Scholar 

  3. Penn I. Cancer in immunosuppressed patients. Transplant Proc 1984; 16:492–4.

    PubMed  CAS  Google Scholar 

  4. Beynet DP, Wee SA, Horwitz SS, et al. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Arch Dermatol 2004; 140:1140–6.

    Article  PubMed  Google Scholar 

  5. Samolitis NJ, Bharadwaj JS, Weis JR, et al. Post-transplant lymphoproliferative disorder limited to the skin. J Cutan Pathol 2004; 31:453–7.

    Article  PubMed  Google Scholar 

  6. Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.

    Google Scholar 

  7. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323:1767–9.

    PubMed  CAS  Google Scholar 

  8. Costes-Martineau V, Delfour C, Obled S, et al. Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review. J Clin Pathol 2002; 55:868–71.

    Article  PubMed  CAS  Google Scholar 

  9. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978; 83:492–502.

    PubMed  CAS  Google Scholar 

  10. Gonthier DM, Hartman G, Holley JL. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 1992; 19:600–3.

    PubMed  CAS  Google Scholar 

  11. McGregor JM, Yu CC, Lu QL, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 1993; 29:549–54.

    Article  PubMed  CAS  Google Scholar 

  12. Pacheco TR, Hinther L, Fitzpatrick J. Extramedullary plasmacytoma in cardiac transplant recipients. J Am Acad Dermatol 2003; 49:S255–8.

    Article  PubMed  Google Scholar 

  13. Verma S, Frambach GE, Seilstad KH, et al. Epstein–Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin. J Cutan Pathol 2005; 32:474–83.

    Article  PubMed  Google Scholar 

  14. Chai C, White WL, Shea CR, et al. Epstein–Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol 1999; 26:242–7.

    Article  PubMed  CAS  Google Scholar 

  15. Blokx WA, Andriessen MP, van Hamersvelt HW, et al. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. Am J Dermatopathol 2002; 24:414–22.

    Article  PubMed  Google Scholar 

  16. Bruce AJ, Subtil A, Rogers RS III, et al. Monomorphic Epstein–Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:e24–8.

    Article  PubMed  Google Scholar 

  17. Steinberg MJ, Herrera AF, Barakat RG. Posttransplant lymphoproliferative disorder resembling a chronic orocutaneous infection in an immunosuppressed patient. J Oral Maxillofac Surg 2004; 62:1033–7.

    Article  PubMed  Google Scholar 

  18. Schumann KW, Oriba HA, Bergfeld WF, et al. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol 2000; 42:923–6.

    Article  PubMed  CAS  Google Scholar 

  19. Oda D, Persson GR, Haigh WG, et al. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation 1996; 61:435–40.

    CAS  Google Scholar 

  20. Nicol I, Boye T, Carsuzaa F, et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 2003; 149:889–91.

    Article  PubMed  CAS  Google Scholar 

  21. Tessari G, Fabbian F, Colato C, et al. Primary cutaneous plasmacytoma after rejection of a transplanted kidney: case report and review of the literature. Int J Hematol 2004; 80:361–4.

    Article  PubMed  Google Scholar 

  22. Tas S, Simonart T, Dargent J, et al. Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation. Ann Dermatol Venereol 2000; 127:488–91.

    PubMed  CAS  Google Scholar 

  23. Unholzer A, Starz H, Hirschsteiner O, et al. Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient. J Dtsch Dermatol Ges 2005; 3:46–51.

    PubMed  Google Scholar 

  24. Lok C, Viseux V, Denoeux JP, et al. Post-transplant cutaneous T-cell lymphomas. Crit Rev Oncol Hematol 2005; 56:137–45.

    Article  PubMed  CAS  Google Scholar 

  25. Seckin D, Demirhan B, Oguz Gulec T, et al. Posttransplantation primary cutaneous CD30 (Ki-1)-positive large-cell lymphoma. J Am Acad Dermatol 2001; 45:S197–9.

    Article  PubMed  CAS  Google Scholar 

  26. Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol 2006; 54:668–75.

    Article  PubMed  Google Scholar 

  27. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005; 32:647–74.

    Article  PubMed  Google Scholar 

  28. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768–85.

    Article  PubMed  CAS  Google Scholar 

  29. Lucioni M, Ippoliti G, Campana C, et al. EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant 2004; 4:1915–20.

    Article  PubMed  Google Scholar 

  30. Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathol Int 2004; 54:649–58.

    Article  PubMed  CAS  Google Scholar 

  31. LaCasce AS. Post-transplant lymphoproliferative disorders. Oncologist 2006; 11:674–80.

    Article  PubMed  Google Scholar 

  32. Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein–Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997; 176:1462–7.

    Article  PubMed  CAS  Google Scholar 

  33. Verma S, Nuovo GJ, Porcu P, et al. Epstein–Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 2005; 32:35–9.

    Article  PubMed  Google Scholar 

  34. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000; 96:3279–81.

    PubMed  CAS  Google Scholar 

  35. Kremers WK, Devarbhavi HC, Wiesner RH, et al. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant 2006; 6:1017–24.

    Article  PubMed  CAS  Google Scholar 

  36. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005; 56:155–67.

    Article  PubMed  Google Scholar 

  37. Cerroni L, Zochling N, Putz B, et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24:457–61.

    Article  PubMed  CAS  Google Scholar 

  38. Kaye FJ, Bunn PA Jr, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321:1784–90.

    PubMed  CAS  Google Scholar 

  39. Vonderheid EC, Tan ET, Kantor AF, et al. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989; 20:416–28.

    Article  PubMed  CAS  Google Scholar 

  40. Zackheim HS, Epstein EH Jr, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990; 22:802–10.

    Article  PubMed  CAS  Google Scholar 

  41. Child FJ, Mitchell TJ, Whittaker SJ, et al. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. Clin Exp Dermatol 2004; 29:231–6.

    Article  PubMed  CAS  Google Scholar 

  42. Stadler R, Otte HG, Luger T, et al. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998; 92:3578–81.

    PubMed  CAS  Google Scholar 

  43. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46:95–106.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Faculty of Medicine, Başkent University, 06490, 5. sokak No. 48, Bahçelievler, Ankara, Turkey

    Deniz Seçkin

  2. Department of Dermatology, University Hospital,Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland

    Günther F.L. Hofbauer

Authors
  1. Deniz Seçkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Günther F.L. Hofbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Dermatologie Venerologie und Allergologie, Charité - Universitätsklinikum Berlin Charite Campus Mitte Klinik und Poliklinik for Dermatologie, Charitéplatz 1, 10117 Berlin, Germany

    Eggert Stockfleth MD, PhD  & Claas Ulrich  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Seçkin, D., Hofbauer, G.F. (2009). Cutaneous Lymphomas. In: Stockfleth, E., Ulrich, C. (eds) Skin Cancer after Organ Transplantation. Cancer Treatment and Research, vol 146. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78574-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78574-5_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-78573-8

  • Online ISBN: 978-0-387-78574-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation